Ananya Banerjee

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Long Non Coding Rna

Cancer Stem Cells

Top Venues

Cancer research

Nanomedicine (London, England)

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ananya Banerjee, Shurui Cai, Guozhen Xie, Na Li, Xuetao Bai, Kousalya Lavudi, Kevin Wang, Xiaoli Zhang, Junran Zhang, Srinivas Patnaik, Floor J Backes, Chad Bennett, Hongbing Wang
A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition. Cancers 14 (9) (2022)
Chaitali Surve, Ananya Banerjee, Anupriya S, Rajasree Chakraborty, Dhiraj Kumar, Ramesh Butti, Mahadeo Gorain, Sabyasachi Parida, Gopal C Kundu, Supriya Shidhaye, Srinivas Patnaik
Antiproliferative and apoptotic potential of methotrexate lipid nanoparticles in a murine breast cancer model. Nanomedicine (London, England) 17 (11) (2022)
Amit K Srivastava, Ananya Banerjee, Tiantian Cui, Chunhua Han, Shurui Cai, Lu Liu, Dayong Wu, Ri Cui, Zaibo Li, Xiaoli Zhang, Guozhen Xie, Karuppaiyah Selvendiran, Srinivas Patnaik, Adam R Karpf, Jinsong Liu, David E Cohn, Qi-En Wang
Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer. Cancer research 79 (9) (2019)
Lu Liu, Shurui Cai, Chunhua Han, Ananya Banerjee, Dayong Wu, Tiantian Cui, Guozhen Xie, Junran Zhang, Xiaoli Zhang, Eric M McLaughlin, Ming Yin, Floor J Backes, Arnab Chakravarti, Yanfang Zheng, Qi-En Wang
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2-/- Ovarian Cancer Cells. Molecular cancer therapeutics 19 (1) (2019)